Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide in Functional Dyspepsia
NCT06841406Phase 4Recruiting
- Sponsor
- UZ Leuven
- Start
- May 2024
- Primary completion
- May 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of EPI-EE in functional dyspepsia (FD), sponsored by UZ Leuven. Started May 2024; status: recruiting.
02
Drugs
EPI-EE
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT06841406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06841406.